Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 40 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 63%

Novo Nordisk Nouvelles

Eli Lilly,Pharmaceutical Companies,Salveen Richter

GLP-1 weight-loss drugs have been major revenue generators for pharmaceutical companies such as Eli Lilly (LLY) and Novo Nordisk (NVO). Goldman Sachs US Lead...

). Goldman Sachs US Lead Biotechnology Analyst Salveen Richter joins Catalysts to discuss the state of the weight-loss market and the potential headwinds for these pharmaceutical companies.She notes that Eli Lilly and Novo Nordisk are facing limited supply as demand skyrockets.

And then we're watching Regeneron as a player going after the quality or body proportionality of weight loss.So they're trying to address that side of the story. Um So I think when we start to see them expand on manufacturing, but also these new entrants coming in who have manufacturing capa capacity like Amgen talked about at length about their ability to manufacture here that should kind of aid and also you'll have a differentiated approach, right?So I mean, when it comes to the ability to meet that demand, right?What every what so many of these bigger players are doing, trying to address that.

And so I think there's going to be significant investment, maybe there's a way to use contract manufacturing organizations and bring them into the process here.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 47. in BE

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Eli Lilly's new Alzheimer's treatment could 'lift' drug marketEli Lilly (LLY) is one step closer to getting its new Alzheimer's treatment approved by the Food and Drug Administration (FDA) after a panel voted to...
La source: YahooFinanceCA - 🏆 47. / 63 Lire la suite »